Inventor

KIM SANG GEON

KR10 patents

⚠️ This page may combine multiple inventors who share the name “KIM SANG GEON”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

KIM SANG GEON

2 patents

US9370504B2Jun 21, 2016

Pharmaceutical composition containing 1,2-dithiolthione derivative for preventing or treating disease caused by overexpression of LXR-α

KIM SANG GEON4 citations63

US8158170B2Apr 17, 2012

Pharmaceutical composition comprising metadoxine and garlic oil for preventing and treating alcohol-induced fatty liver and steatohepatitis

KIM SANG GEON0 citations44

YOUNG HEE KIM

1 patent

US6113909ASep 5, 2000

Pharmaceutical composition containing a mixed extract of Phellodendron amurense RUPRECHT cortex and Patrinia scabiosaefolia FISCH. for treatment of hepatitis C

YOUNG HEE KIM19 citations85

KIM NAK DOO

1 patent

US5658913AAug 19, 1997

Chemopreventive compounds and a preparation method and use thereof

KIM NAK DOO13 citations65

HAN YUNG BOK

1 patent

US5891864AApr 6, 1999

Anti-cancer compositions

HAN YUNG BOK14 citations62

KWON SOON KYOUNG

1 patent

US5942511AAug 24, 1999

Allylthiopyridazine derivatives and process for preparing the same

KWON SOON KYOUNG5 citations51

CJ CHEILJEDANG CORP

1 patent

US7435819B2Oct 14, 2008

4,5,6,7-tetrahydro-[1,2]dithiolo[4,3-C] pyridine-3-thione compounds

CJ CHEILJEDANG CORP1 citations49

SNU R&DB FOUNDATION

1 patent

US9745280B2Aug 29, 2017

Compound or pharmaceutically acceptable salt thereof, and pharmaceutical composition containing same as active ingredient

SNU R&DB FOUNDATION0 citations48

APHARMA

1 patent

US12398202B2Aug 26, 2025

Use of ITIH1 as biomarker for detection of insulin resistance in diseases accompanied by impaired glucose tolerance

APHARMA0 citations42

SANG GEON KIM

1 patent

US7078045B2Jul 18, 2006

Pharmaceutical composition for treatment and prevention of liver fibrosis and cirrhosis

SANG GEON KIM1 citations42